AIR insulin + insulin glargine

AIR insulin + insulin glargine is a combination of two types of insulins intended for the management of diabetes mellitus. Insulin glargine is a long-acting recombinant human insulin analog that provides basal glycemic control by mimicking the body’s natural, steady release of insulin over approximately 24 hours. It works by facilitating glucose uptake into tissues and suppressing hepatic glucose production[1][3][4]. "AIR insulin" does not correspond to any recognized or approved pharmaceutical product, code name, or formulation in current medical literature or regulatory databases as of June 2025. The combination as stated does not match any known marketed product or investigational therapy.